Shandong Boan Biotechnology Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '24 Oct 9, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,306	7,894	10,084	-	-
Market Cap Growth	-44.79%	-21.72%	-	-	-
Enterprise Value	5,832	7,949	9,909	-	-
Last Close Price	9.90	15.50	19.80	-	-
PE Ratio	75.92	-60.02	-26.32	-	-
PS Ratio	6.52	11.59	17.29	-	-
PB Ratio	3.37	5.43	6.29	-	-
P/FCF Ratio	-40.82	-83.42	-31.50	-	-
P/OCF Ratio	-106.80	-385.89	-44.19	-	-
EV/Sales Ratio	7.54	11.67	16.99	-	-
EV/EBITDA Ratio	84.28	-94.51	-29.96	-	-
EV/EBIT Ratio	273.67	-55.53	-25.59	-	-
EV/FCF Ratio	-51.94	-84.00	-30.96	-	-
Debt / Equity Ratio	0.48	0.31	0.21	0.17	0.03
Debt / FCF Ratio	-6.34	-4.73	-1.07	-0.75	-0.03
Asset Turnover	0.31	0.27	0.24	0.11	-
Inventory Turnover	1.10	1.35	1.33	0.88	-
Quick Ratio	0.93	0.76	0.98	2.84	0.09
Current Ratio	1.35	1.09	1.80	3.61	0.23
Return on Equity (ROE)	4.58%	-8.72%	-22.34%	-22.17%	-
Return on Assets (ROA)	0.53%	-3.59%	-9.94%	-9.17%	-
Return on Capital (ROIC)	0.68%	-4.71%	-12.11%	-11.95%	-
Earnings Yield	1.45%	-1.67%	-3.72%	-	-
FCF Yield	-2.45%	-1.20%	-3.17%	-	-
Buyback Yield / Dilution	-1.06%	-2.14%	-4.19%	-1119.88%	-
Total Shareholder Return	-1.06%	-2.14%	-4.19%	-1119.88%	-

Source: S&P Capital IQ. Standard template. Financial Sources.